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        In the Western world, cardiovascular diseases 
remain the leading cause of mortality and mor-
bidity (  1  ). Moreover, the increasing mean age 
of the population has altered the spectrum of 
cardiac diseases toward heart failure. Heart fail-
ure is a progressive disorder that is initiated 
by a loss of cardiomyocytes (  2, 3  ). The primary 
event can be either acute, as in the case of 
myocardial infarction, or gradual, as in the case 
of hemodynamic overload, for instance in pa-
tients suff  ering from chronic hypertension. In 
the classical view, the heart contains at birth a 
predetermined number of cardiomyocytes, the 
loss of which cannot be compensated for, and 
the adaptive response of the heart to stress relies 
exclusively on cardiomyocyte hypertrophy. 
Several groups have, however, identifi  ed resi-
dent cells in the heart with properties of cardiac 
precursor cells (CPCs) (  4  –  7  ). The existence of 
CPCs suggests that cardiac integrity also de-
pends on a balance between cell death and cell 
production. Therefore, to understand the cel-
lular mechanisms of cardiac adaptation, we 
need to identify pathways controlling cardio-
myocyte growth as well as that regulating the 
level of the cardiac progenitor pool and its 
commitment toward the cardiogenic lineage. 
  The Notch signaling pathway is crucial in 
the development of metazoans (  8, 9  ). It has also 
been implicated in the regeneration of adult 
self-renewing tissues (  10, 11  ). In mammals, sig-
naling occurs after the interaction of one of the 
four Notch receptors (Notch1  –  4) with mem-
brane-bound ligands of the Jagged (Jagged1 
and 2) and Delta-like (Delta-like1, 3, and 4) 
family. Therefore, the Notch pathway is essen-
tially a communication system between two 
adjacent cells, a signal-sending cell expressing 
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  In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. 
The recent discovery of cardiac stem cells in the postnatal heart, however, suggests that 
these cells could participate in the response to stress via their capacity to regenerate 
cardiac tissues. Using models of cardiac hypertrophy and failure, we demonstrate that 
components of the Notch pathway are up-regulated in the hypertrophic heart. The Notch 
pathway is an evolutionarily conserved cell-to-cell communication system, which is crucial 
in many developmental processes. Notch also plays key roles in the regenerative capacity of 
self-renewing organs. In the heart, Notch1 signaling takes place in cardiomyocytes and in 
mesenchymal cardiac precursors and is activated secondary to stimulated Jagged1 expres-
sion on the surface of cardiomyocytes. Using mice lacking Notch1 expression specifi  cally in 
the heart, we show that the Notch1 pathway controls pathophysiological cardiac remodel-
ing. In the absence of Notch1, cardiac hypertrophy is exacerbated, fi  brosis develops, func-
tion is altered, and the mortality rate increases. Therefore, in cardiomyocytes, Notch 
controls maturation, limits the extent of the hypertrophic response, and may thereby 
contribute to cell survival. In cardiac precursors, Notch prevents cardiogenic differentiation, 
favors proliferation, and may facilitate the expansion of a transient amplifying cell 
compartment. 
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pathway has also been implicated in cardiac morphogenesis 
(  15, 16  ). Notch plays a crucial role in the regulation of endocar-
dial epithelial-to-mesenchymal transformation in the primary 
heart tube during septation and formation of the valves (  17, 18  ). 
Notch1 is the main receptor subtype found in the endocardial 
layer in the outfl  ow tract of the developing heart (  19  ). Interest-
ingly, Notch1 haploinsuffi   ciency in human results in heart dis-
ease characterized by cardiac valve calcifi  cation and ventricular 
septal defects (  20  ). Furthermore, patients suff  ering from Alagille 
syndrome, an autosomal dominant disorder caused by mutations 
in the   Jagged1   gene, demonstrate severe cardiac abnormalities in-
cluding tetralogy of Fallot (  21, 22  ). Therefore, the importance of 
the Notch pathway in cardiac development has been extensively 
studied but its role in the postnatal heart has not been investi-
gated. In the present study, we demonstrate that cardiac remod-
eling, which develops secondary to hemodynamic overload or 
in response to chronic agonist stimulation in the adult heart, is in 
part regulated by the Notch1 receptor pathway. Importantly, 
Notch signaling is observed in both cardiomyocytes and mesen-
chymal CPCs. In cardiomyocytes, Notch represses cardiac gene 
expression and prevents an excessive and detrimental hypertro-
phic response. In CPCs, Notch appears to regulate proliferation 
and diff  erentiation. 
    RESULTS   
  The Notch pathway is activated in cardiac myocyte 
and nonmyocyte cells 
  Agonist-induced cardiac hypertrophy in TG1306/1R trans-
genic mice with cardiac angiotensin II overproduction leads 
the ligand and a signal-receiving cell expressing the receptor. 
The Notch protein is synthesized as a single polypeptide that 
is cleaved by proteases during posttranslational processing. 
The two portions of the protein, however, remain associated 
and form a functional heterodimer on the cell surface. Upon 
activation, the Notch receptor is subjected to two additional 
cleavages by TACE (TNF-     converting enzyme) and by a 
multicomponent     -secretase complex, thus releasing the 
Notch intracellular domain. This fragment enters the nucleus, 
binds to a transcription factor known as RBP-J in the mouse, 
recruits coactivators, and up-regulates target gene transcrip-
tion. Prototypic target genes of Notch are bHLH (basic he-
lix-loop-helix) repressors of the   Hairy/enhancer of split   (  Hes  ) 
family. The   Hes   family includes   Hes-1   and   Herp   (Hairy-re-
lated transcription factors) also known as   Hey   (  12  ). 
  The biological eff  ects of Notch activation are extremely 
context dependent. In certain situations, Notch restricts cell fate 
and maintains an undiff  erentiated state in uncommitted progeni-
tors, whereas in others Notch produces inductive signaling that 
stimulates cells to adopt a particular fate ( 11  ). For instance, Notch 
preserves stem cell pools, regulates lateral inhibition, and con-
trols asymmetrical divisions but has also been shown to induce 
terminal diff  erentiation. Cell fate decisions and diff  erentiation 
during hematopoiesis and lymphopoiesis are controlled by 
Notch. In hemangioblasts, Notch signaling could specify hema-
topoietic versus endothelial cell fate. In the adult, Notch regu-
lates T versus B cell lineage decisions (  13  ). Furthermore, Notch 
plays an important role in arteriovenous patterning, in regulating 
endothelial tip cell and vessel wall formation (  14  ). The Notch 
    Figure 1.         Notch signaling is activated in cardiac myocytes and nonmyocyte cells in the adult heart.   (A) Quantitative real-time RT-PCR analysis 
of gene expression showing the up-regulation of Notch1, Jagged1, and Hes1 in hypertrophic (H) and dilated (D) hearts of TG1306/1R transgenic mice 
relative to hearts of WT mice. The relative expression levels of BNP and     -skeletal actin are also shown. Asterisks denote signifi  cant difference between 
the groups (P   <   0.05).   n   = 6 per group. Error bars show the mean   ±   SD. (B) Confocal immunofl  uorescence analysis of activated Notch1 in adult mouse 
myocardium. Tissue sections were stained with an antibody directed against the intracellular domain of proteolytically cleaved Notch1 (N1IC). Cardio-
myocytes were revealed using anti  –      -actinin antibody. Laminin immunostaining was used to delimit cell boundaries, and nuclei were stained with DAPI. 
Closed and open arrows indicate cardiomyocytes and CPCs, respectively. Bars, 10   μ  m.     JEM VOL. 205, December 22, 2008 
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to a gradual transition from a compensatory state to heart 
failure (  23, 24  ). To gain insight into the molecular mecha-
nisms that play a role in maintaining cardiac integrity in the 
diseased heart, we performed a comparative study of gene 
expression between normal and stressed hearts using microar-
ray analysis. TG1306/1R transgenics were separated into two 
phenotypic groups based on morphological parameters (car-
diac weight index and histology) and either a moderate or a 
high up-regulation of markers of hypertrophy and failure 
(Table S1, available at http://www.jem.org/cgi/content/
full/jem.20081427/DC1) and compared with age- and sex-
matched WT. Microarray data revealed that several genes 
belonging to pathways important during cardiac morphogen-
esis were activated in hypertrophic and dilated adult hearts 
(Tables S2  –  S7). In particular, the activated genes were those 
encoding the Notch1 receptor, its ligand Jagged1, the tran-
scription factor RBP-J, and the target gene of Notch Hes1. 
These results were confi  rmed using quantitative RT-PCR 
(  Fig. 1 A  ).   First, both dilated and hypertrophic hearts demon-
strated signifi  cant up-regulation of brain natriuretic peptide 
(BNP) and     -skeletal actin expression, two markers of car-
diac stress. BNP and     -skeletal actin were more expressed in 
the dilated than in the hypertrophic heart as expected. More 
importantly, there was a 15  –  20-fold increase in cardiac ex-
pression of the Notch1 receptor, whereas Jagged1 expression 
was up-regulated     10-fold. Expression of both the Notch1 
receptor and its ligand was higher in the dilated hearts than in 
the hypertrophic hearts. Accordingly, Hes1 expression was 
also signifi  cantly up-regulated in the stressed adult hearts. 
  To identify cardiac cells in which the Notch pathway was 
activated, we performed immunohistological analysis of adult 
heart tissue using antibodies directed against N1IC (the in-
tracellular domain of Notch1), the cleaved portion of the 
    Figure 2.         Inhibition of Notch signaling exacerbates cardiac hyper-
trophy.   (A) Quantitative real time RT-PCR analysis of expression of 
Notch1, Jagged1, and Notch target genes Hes1, Hey1, and Hey2 in the 
hearts of WT and TG13061/R transgenic mice treated with the    -secretase 
inhibitor Ly411,575 relative to their vehicle-treated counterparts. 
(B) Quantitative RT-PCR analysis of expression of markers of cardiac hy-
pertrophy and failure in the hearts of WT and transgenic mice, treated as 
in A, relative to vehicle-treated mice. (C) Representative transverse histo-
logical sections showing exacerbated hypertrophy in hearts from 
TG1306/1R transgenic mice treated with the    -secretase  inhibitor 
Ly411,575 compared with control mice. (D) The heart weight/body weight 
ratio (cardiac weight index [CWI]) of vehicle- and    -secretase  inhibitor –
  treated transgenic and WT mice is represented. Asterisks denote signifi  -
cant difference between the groups (P   <   0.05).   n   = 6  –  8 mice per group. 
Error bars show the mean   ±   SD. Bar, 2 mm.     
    Table I.        Physiological and echocardiographic parameters in mice treated with the     -secretase inhibitor LY411,575 
WT TG1306/1R
Vehicle (  n   = 5  –  6) Inhibitor (  n   = 6) Vehicle (  n   = 6) Inhibitor (  n   = 6)
  Heart weight   (mg) 122.8   ±   7.1 125.5   ±   11.1 141.3   ±   7.8 183.7   ±   14.3**
  Body weight   (g) 24.9   ±   1.0 25.0   ±   0.4 26.8   ±   0.9 26.1   ±   1.1
  Heart weight/body weight ratio   (mg/g) 4.9   ±   0.2 5.0   ±   0.5 5.3   ±   0.2 7.1   ±   0.7**
  Blood pressure   (mm Hg) 114.4   ±   2.7 111.0   ±   5.2 114.7   ±   3.6 113.6   ±   3.8
  Heart rate   (bpm) 611   ±   14 609   ±   6 617   ±   6 606   ±   16
  Left ventricular wall thickness   (mm)
       diastole 1.57    ±   0.04 1.59   ±   0.10 1.66   ±   0.09 2.14   ±   0.13*  †    † 
       systole 1.99    ±   0.03 1.90   ±   0.12 1.98   ±   0.10 2.39   ±   0.13**  †    † 
  Left ventricular diameter   (mm)
       diastole 3.03    ±   0.04 2.87   ±   0.15 3.12   ±   0.15 3.23   ±   0.13*  †    † 
       systole 1.73    ±   0.06 1.55   ±   0.06 1.71   ±   0.14 1.59   ±   0.06
  Septum thickness   (mm)
       diastole 0.33    ±   0.02 0.38   ±   0.02 0.33   ±   0.03 0.34   ±   0.03
       systole 0.46    ±   0.02 0.48   ±   0.01 0.39   ±   0.05 0.51   ±   0.06
  Fraction of shortening   (%) 43.1   ±   1.6 45.8   ±   1.0 45.7   ±   2.2 50.7   ±   1.2**  †    † 
Statistical signifi  cance: *, P   <   0.05 and **, P   <   0.01 as compared to corresponding vehicle-treated groups;   †  , P   <   0.05 and   †    †  , P   <   0.01 as compared to corresponding WT 
groups.3176 NOTCH1-MEDIATED CARDIAC RESPONSE TO STRESS   | Croquelois et al. 
transgenic mice under     -secretase inhibition. Administration of 
the     -secretase inhibitor had no eff  ects on cardiac structure and 
function in WT animals despite a demonstrated blockade of the 
Notch pathway (  Fig. 2   and   Table I  ). 
  Notch1 receptor-mediated activation of the Notch pathway 
in the heart 
  To study the activation of the Notch pathway at the onset of 
the hypertrophic response, we used a model of renovascular 
hypertension, namely the 1K1C (one kidney, one clip) model, 
which produces hemodynamic overload and induces cardiac 
remodeling (  27  ). Immunohistochemistry was performed to 
quantify the number of N1IC-positive cells to evaluate the 
Notch1 receptor. In initial experiments, we analyzed Notch 
activation in cardiac cells expressing the stem cell antigen 
(Sca) 1 because this marker has been previously used to iden-
tify resident CPCs (Fig. S1 A, available at http://www.jem
.org/cgi/content/full/jem.20081427/DC1). Clearly, N1IC 
staining was not limited to the Sca-1  –  positive population in 
the adult heart in WT mice or in TG1306/1R transgenics. 
Furthermore, not only nonmyocyte cells but also some car-
diomyocytes were positive for N1IC staining. In diff  erent 
experiments, we isolated the mesenchymal fraction from 
neonatal mouse hearts, which was shown previously to con-
tain Sca-1  –  positive precursor cells. Approximately 35% of 
cells stained positive for Sca-1 in this fraction. However, very 
few if any cells expressing Sca-1 demonstrated Notch1 acti-
vation (Fig. S1 B). Based on these results, we decided to use 
a diff  erent approach, which consisted of analyzing all cardiac 
N1IC-positive cells and not a preselected subpopulation. To 
distinguish between cardiac myocytes and nonmyocyte cells 
and to identify cellular boundaries, sarcomeric     -actinin and 
-laminin stainings were simultaneously performed.   Fig. 1 B   
depicts a representative experiment, which demonstrates that 
N1IC was present in the nuclei of both cardiomyocytes 
(    -actinin positive, closed arrows) and nonmyocyte cells (    -
actinin negative, open arrows). Not all cardiac myocytes dem-
onstrated N1IC staining. Similarly, small N1IC-positive cardiac 
undiff  erentiated cells, which clustered in the interstitial mes-
enchyme between cardiac fi  bers, were readily detected. 
  The Notch pathway regulates the cardiac response 
to hypertrophic stress in vivo 
  To determine whether the Notch pathway plays a func-
tional role during the development of cardiac hypertrophy, 
TG1306/1R transgenics were administrated with a     -secretase 
inhibitor (LY411,575). This compound was previously shown 
to block both the proteolytic release of N1IC and the specifi  c 
activation of Notch target gene expression (  25  ). The drug was 
injected into 15-wk-old mice to investigate the role of Notch 
during the compensatory phase of the cardiac response to stress. 
To verify eff  ective Notch inhibition, the percentage of marginal 
zone B (MZB) cells in the spleen (i.e., B220  +   and CD21  +  , 
CD23        splenocytes), which strictly depend on active Notch 
signaling (  26  ), was measured by FACS analysis (Fig. S2, 
A and B, available at http://www.jem.org/cgi/content/full/
jem.20081427/DC1). Treatment with the     -secretase inhibitor 
resulted in a dramatic decrease in MZB cells, demonstrating 
successful Notch inhibition. Importantly, the expression of 
Hes1, Hey1, and Hey2, as well as of Notch1 and Jagged1, was 
down-regulated in the hearts of transgenics receiving the inhibi-
tor (  Fig. 2 A  ).   Treatment resulted in a concomitant stimulation 
of expression of cardiac makers of hypertrophy in treated hearts 
(  Fig. 2 B  ). Furthermore, transgenic mice developed more hy-
pertrophy upon Notch blockade than did vehicle-treated trans-
genics (  Fig. 2, C and D  ; and   Table I  ).   Blood pressure and heart 
rate remained unaff  ected (  Table I  ). Finally, echocardiography 
confi  rmed the thickening of the left ventricular wall and re-
vealed a signifi  cantly increased fraction of shortening in the 
    Figure 3.         Notch1 controls the adaptive cardiac response to stress.  
(A) Quantitation of Notch1 activation in the adult stressed heart. Heart 
tissue sections from clipped (1K1C) and sham-operated (sham) mice were 
stained with an antibody against proteolytically activated N1IC at 8 and 
20 d after clipping. The N1IC-positive nuclei were counted in representa-
tive sections and represented as percentage of total nuclei.   n   =  5 – 8  areas 
per section and 3 mice per group. (B and C) Quantitative RT-PCR analysis 
of the expression of cardiac marker genes in sham and 1K1C mice. N1  Del , 
mice lacking Notch1 in the heart.   n   = 5  –  7 mice per group. Error bars show 
the mean   ±   SD. (D) Development of cardiac fi  brosis in mice lacking 
Notch1 in the heart. Heart tissue sections from sham and clipped WT and 
N1  Del   mice were subjected to van Gieson staining to reveal fi  brosis (red). 
(E) Mortality rate in clipped and sham-operated WT mice and mice lacking 
Notch1 in the heart (N1  Del ).   n   = 20  –  25 mice per group. Asterisks in A, B, 
and C denote signifi  cant difference (P   <   0.01). Bar, 2 mm.     JEM VOL. 205, December 22, 2008 
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tions of hemodynamic overload than normal littermates 
(  Fig. 3 E  ). To evaluate whether increased fi  brosis and de-
creased cardiac function were caused by accelerated cardio-
myocyte loss, we determined the rate of apoptosis using 
TUNEL assay.   Fig. 4 A   shows apoptotic cardiomyocytes 
in the stressed heart of cNotch1 KOs.   Quantitative analy-
sis demonstrated that the number of TUNEL-positive cells 
was greater in 1K1C mice lacking Notch1 than in WT 
(  Fig. 4 B  ). 
  To investigate the role of the Notch pathway in cardiac 
myocytes, we studied neonatal mouse cardiomyocytes iso-
lated from WT and cNotch1 KOs (  Fig. 5 A  ).   When stained 
for N1IC, cultured WT cardiomyocytes demonstrated two 
diff  erent distribution patterns. Some cells were characterized 
by intense nuclear N1IC staining. Diff  use myomesin staining 
suggested that these cells were poorly diff  erentiated or in the 
process of dediff  erentiation. In contrast, mature diff  erentiated 
cardiomyocytes with organized sarcomeres showed little or no 
N1IC staining. Notch1-defi  cient cardiomyocytes presented a 
state of maturation that appeared to be even more advanced 
than that of the WT diff  erentiated population. Furthermore, 
the expression of cardiac genes in myocytes isolated from 
mutant animals was strikingly up-regulated as compared with 
WT cells (  Fig. 5 B  ). Interestingly, the expression of the     -
MHC gene (a marker of cardiac maturation) was highly stim-
ulated in cardiomyocytes lacking Notch1, whereas     -MHC 
gene expression (a maker of cardiac hypertrophy) was similar 
to that measured in WT cells. Finally, we demonstrated that 
the N1IC staining decreased markedly in phenylephrine-
treated WT cardiomyocytes, suggesting that inactivation of 
Notch1 signaling could also be necessary for the initiation of 
the hypertrophic response (Fig. S3, available at http://www
.jem.org/cgi/content/full/jem.20081427/DC1). 
size of the cardiac cell population with an activated Notch 
pathway (  Fig. 3 A  ).   Approximately 80% of the N1IC-posi-
tive cells in the normal adult heart were cardiomyocytes, and 
this percentage was not strikingly modifi  ed under stress. 
However, hearts from clipped mice showed an increased num-
ber of N1IC-positive cells 8 d after surgery. This number de-
creased to levels observed in sham-operated animals after 20 d. 
Because the Notch1 receptor was the predominant form 
expressed in the adult heart, we evaluated the physiological 
importance of this receptor using conditional Notch1 KOs. 
Thus, MLC2v-Cre mice with cardiac-specifi  c expression of the 
Cre recombinase (  28  ) were crossed to Notch1  lox/lox   animals (  29  ). 
Mice with cardiac-specifi  c Notch1 deletion (Notch1  lox/lox  ; 
MLC2v-Cre, thereafter cNotch1 KOs) reached adulthood 
and appeared grossly normal (unpublished data). To evaluate 
the heart under stress, work overload was induced using the 
hypertensive 1K1C model. 8 wk after clipping, WT and 
cNotch1 KOs developed the same level of hypertension with 
comparable heart rates (  Table II  ).   Heart weight/body weight 
ratio was similar in both hypertensive groups. However, 
echographic analysis revealed several diff  erences (  Table II  ). 
The left ventricular free wall was thicker in mutant mice. In 
addition, cNotch1 KOs had a larger left ventricular diameter 
in systole along with a decreased fractional shortening when 
compared with controls. This paralleled an increase in the 
expression of cardiac markers of hypertrophy in the hearts of 
hypertensive KOs (  Fig. 3, B and C  ). Moreover, marked fi  bro-
sis was detected in the hypertrophic hearts of mice lacking 
Notch1 (  Fig. 3 D  ). Quantitation of extracellular matrix accu-
mulation demonstrated an     10-fold diff  erence between hearts 
from hypertensive WT and Notch1-defi  cient animals (un-
published data). Finally, mice with cardiac-specifi  c Notch1 
deletion also showed a higher rate of mortality under condi-
    Table II  .      Physiological and echocardiographic parameters in sham-operated and 1K1C mice lacking Notch1 in the heart 
WT cNotch1 KOs
Sham (  n   = 4  –  6) 1K1C (  n   = 5  –  6) Sham (  n   = 4  –  6) 1K1C (  n   = 5  –  8)
  Heart weight   (mg) 96.3   ±   3.6 156.2   ±   11.2 ** 97.3   ±   3.6 144.2   ±   1.3 **
  Body weight   (g) 26.0   ±   0.6 27.2   ±   0.7 25.7   ±   0.7 26.2   ±   0.8
  Heart weight/body weight ratio   (mg/g) 3.7   ±   0.1 5.8   ±   0.5 ** 3.8   ±   0.1 5.5   ±   0.5 **
  Blood pressure   (mm Hg) 117.1   ±   4.3 149.0   ±   3.2 ** 120.3   ±   2.3 148.0   ±   3.2 **
  Heart rate   (bpm) 556   ±   90 528   ±   51 640   ±   20 561   ±   75
  Left ventricular wall thickness   (mm)
       diastole 1.32    ±   0.04 1.89   ±   0.04 ** 1.39   ±   0.04 2.11   ±   0.04 **  †    † 
       systole 1.75    ±   0.09 2.23   ±   0.07 ** 1.69   ±   0.03 2.43   ±   0.05 **  † 
  Left ventricular diameter   (mm)
       diastole 3.18    ±   0.19 3.17   ±   0.12 2.97   ±   0.07 3.17   ±   0.08
       systole 1.75    ±   0.06 1.60   ±   0.08 1.71   ±   0.07 2.01   ±   0.07 **  †    † 
  Septum thickness   (mm)
       diastole 0.38    ±   0.04 0.39   ±   0.09 0.34   ±   0.02 0.49   ±   0.04 **
       systole 0.48    ±   0.04 0.60   ±   0.13 0.46   ±   0.02 0.61   ±   0.05 **
  Fraction of shortening   (%) 44.8   ±   1.0 49.5   ±   1.5 * 42.4   ±   0.8 36.4   ±   0.8 **  †    † 
Statistical signifi  cance: *, P   <   0.05 and **, P   <   0.01 as compared to corresponding vehicle-treated groups;   †  , P   <   0.05 and   †    †  , P   <   0.01 as compared to corresponding WT 
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labeled cells in the hearts of hypertensive mice lacking Notch1 
was signifi  cantly reduced as compared with their WT litter-
mates (  Fig. 6 E  ). 
  To further analyze the role of Notch in the control of 
postnatal neocardiogenesis, we isolated the cardiac mesen-
chymal fraction from WT neonatal mice, which was previ-
ously shown to contain CPCs (  4  –  7  ). Under conditions that 
favored expansion, CPCs demonstrated nuclear N1IC stain-
ing. These proliferating cells also appeared to be committed 
to the cardiogenic lineage as judged by the colocalization of 
N1IC and Nkx2.5 staining (  Fig. 7 A  , left). After the induc-
tion of diff  erentiation, single Nkx2.5-positive cells were also 
found adjacent to double-positive precursors (  Fig. 7 A  , middle, 
  The Notch pathway controls cardiogenic differentiation 
in the cardiac precursor population 
  Immunostaining analysis revealed that, besides being stimu-
lated in cardiomyocytes, the Notch pathway was also acti-
vated in cells belonging to an undiff  erentiated mesenchymal 
fraction that was shown previously to contain CPCs (  Fig. 1  ). 
Therefore, the expression of GATA4 and Nkx2.5 on cardiac 
nonmyocyte cells was examined in TG1306/1R transgenics 
to evaluate whether mesenchymal Notch signaling cells were 
committed to the cardiogenic lineage. The vast majority of 
undiff  erentiated N1IC-positive cells coexpressed GATA4 
(  Fig. 6 A  ).   In addition, cells with an activated Notch pathway 
expressed Nkx2.5 (  Fig. 6 B  ). N1IC-negative Nkx2.5-posi-
tive cells were also found in the same clusters. Because the 
Notch pathway has been shown to be involved in sustaining 
proliferation in other organs systems, we investigated whether 
N1IC-positive CPCs were actively cycling. First, we dem-
onstrated that CPCs with an activated Notch pathway (N1IC 
positive) and expressing the cell proliferation marker Ki67 
could be readily detected in the adult heart (  Fig. 6 C  ). Using 
laminin staining to identify cell boundaries, we confi  rmed 
that small nonmyocyte cells expressed Ki67. In addition, some 
cardiomyocytes were also Ki67 positive (Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20081427/DC1). 
Furthermore, we quantifi  ed BrdU-positive cells in the stressed 
adult heart using the 1K1C model (  Fig. 6, D and E  ). In WT 
animals, the percentage of BrdU-positive cells increased in 
the stressed heart. Interestingly, the increase in the number of 
    Figure 4.         Increased apoptosis in the heart tissue of clipped N1  Del   
mice.   (A) Heart tissue sections were processed for detection of apoptotic 
nuclei using TUNEL assay and for detection of cardiac myocytes using 
anti-myomesin antibody. Representative photomicrographs of TUNEL-
positive nuclei in     -actinin  –  positive cardiomyocytes and in nonmyocyte 
cells are shown. (B) Quantitative analysis of apoptosis in the hearts of 
clipped mice. Heart tissue sections cut at anatomically equivalent loca-
tions were stained as in A. The total number of TUNEL-positive nuclei per 
section was counted under a fl  uorescence microscope. The bar graph 
represents the mean number of nuclei in sham operated (  n   = 4) and 
clipped (  n   = 4) WT mice and sham (  n   = 3) and clipped (  n   = 5) N1  Del   mice. 
The asterisk denotes signifi  cant difference (P   <   0.05) between clipped WT 
and N1  Del   mice. Error bars show the mean   ±   SD. Bar, 20   μ  m.     
    Figure 5.         Notch1 activation controls maturation and cardiac gene 
expression in cardiomyocytes.   (A) Analysis of Notch1 activation in cul-
tured cardiomyocytes isolated from neonatal mice carrying fl  oxed Notch1 
allele (Notch1  lox/lox )  without  (Cre      ) or with (Cre  +  ) Cre recombinase expres-
sion under the control of the MLC2v promoter. The cultures were stained 
for activated Notch1 (N1IC) and myomesin. The Cre        (WT)  cardiomyocytes 
demonstrate either high (N1IC  hi  ) or low (N1IC  low  ) N1IC staining concomitant 
with poor or elaborate myofi  brillar structure, respectively. (B) Quantitative 
RT-PCR analysis demonstrating the up-regulation of cardiac-specifi  c gene 
expression in cultures of Cre  +   (Notch1 deleted) cardiac myocytes relative to 
Cre        myocyte cultures. Error bars represent the means   ±   SD. Bar, 20   μ  m.    JEM VOL. 205, December 22, 2008 
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sis in isolated CPCs, precursors were cultured in the presence 
of the     -secretase inhibitor DAPT. Treated cells demon-
strated an acceleration of spontaneous diff  erentiation into 
cardiomyocytes (  Fig. 7 C  ). Mesenchymal CPCs were also 
obtained from neonatal cNotch1 KOs. In this population, 
similar to what we observed in WT cells maintained in the 
presence of DAPT, the diff  erentiation toward the cardio-
genic lineage was signifi  cantly advanced. 
  Jagged1 expression is stimulated in the stressed heart 
  Because the adult heart predominantly expressed Jagged1, 
this suggested that it could be the main ligand involved in the 
arrows).   At an even later time point, diff  erentiated     -actinin  –
  positive cardiomyocytes with assembled myofi  brillar appara-
tus appeared in the culture. These cells were N1IC negative 
(  Fig. 7 A  , right, arrows). Cardiogenic diff  erentiation was also 
evident by the enhanced expression of late cardiac-specifi  c 
genes such as cardiac troponin I and       –  myosin heavy chain 
in diff  erentiating cells (  Fig. 7 B  ). Interestingly, a concomitant 
down-regulation of Jagged1 expression was observed in dif-
ferentiating cultures. Expression of Hes1, a direct Notch tar-
get gene, was also diminished. This occurred in the absence 
of Notch1 receptor down-regulation. To evaluate whether 
inhibition of the Notch pathway could stimulate cardiogene-
    Figure 6.         Notch1 activation in proliferating undifferentiated cardiac-committed cells in the adult myocardium.   (A) Confocal microscopy of 
normal heart tissue sections showing activation of Notch1 (N1IC) in GATA4-positive     -actinin  –  negative cells. Nuclei are stained with DAPI. (B) Staining 
of cardiac tissue sections, as in A, showing N1IC staining in Nkx2.5-positive nuclei of undifferentiated     -actinin  –  negative cells. (C) Activation of Notch1 
(N1IC) in proliferating Ki67-positive     -actinin  –  negative cells. (D) Analysis of BrdU incorporation in hearts of clipped (1K1C) and sham-operated (sham) 
WT mice and mice lacking Notch1 in the heart (N1  del  ). Tissue sections of hearts from mice administered with BrdU for 96 h in drinking water were 
stained with anti-BrdU antibody. The BrdU  +   nuclei are red. (E) Quantitation of BrdU incorporation represented as percentage of BrdU  +   nuclei. * and   †   
denote signifi  cance at P   <   0.01 within groups and between groups, respectively. Error bars show the mean   ±   SD. Bars: (A, B, and C) 10   μ m;  (D)  100   μ m.   3180 NOTCH1-MEDIATED CARDIAC RESPONSE TO STRESS   | Croquelois et al. 
expression was markedly up-regulated in all cardiomyocytes 
of TG13061R transgenic mice as compared with their WT 
littermates (  Fig. 8 D  ). 
    DISCUSSION   
  In this study, we show that the Notch pathway regulates the 
cardiac response to stress via the Notch1 receptor. Specifi  -
cally, we demonstrate that: (a) the receptor Notch1 and its 
ligand Jagged1 are the predominant members of the Notch 
family expressed in the adult heart; (b) both Notch1 and Jag-
ged1, as well as the Notch target gene Hes1, are up-regulated 
in the stressed heart; (c) the Notch pathway is activated in the 
cardiomyocyte as well as in CPCs; (d) the Notch pathway 
regulates cardiac gene expression in adult cardiomyocytes and 
controls the extent of the hypertrophic response; (e) the 
Notch pathway controls proliferation and cardiogenesis in 
CPCs; and (f) pharmacological and genetic blockade of the 
Notch pathway in the heart is largely detrimental to the 
stressed heart. Based on these fi  ndings, we propose that Notch 
activation of the Notch pathway. Therefore, we fi  rst deter-
mined the nature of the cardiac cells expressing Jagged1. Jag-
ged1 expression was readily detected in cardiomyocytes. The 
staining pattern, in particular the alignment along the muscle 
fi  bers, was compatible with the expected surface expression 
of Jagged1 (  Fig. 8, A and B  ).   Jagged1 on the surface of car-
diomyocytes could activate both adjacent Notch-expressing 
myocytes and CPCs. Indeed,     -actinin  –  negative Nkx2.5-
positive cells can be observed lying adjacent to Jagged1-ex-
pressing fi  bers (  Fig. 8 B , arrows). We then investigated cardiac 
expression of Jagged1 in the stressed heart using hypertensive 
1K1C WT as well as TG1306/1R transgenic mice (  Fig. 8, 
C and D  ). Sham-operated WT animals in the 1K1C model 
demonstrated a patchy pattern of Jagged1 expression distrib-
uted throughout both cardiac ventricles (  Fig. 8 C  ). In hyper-
tensive 1K1C WT mice, no change was noticed during the 
fi  rst 4 d after induction of the hypertrophic response. However, 
8 and 12 d after induction, there was a dramatic up-regulation 
of Jagged1 expression in the myocardium. Similarly, Jagged1 
    Figure 7.         Notch signaling controls differentiation of CPCs into mature cardiomyocytes.   (A) Analysis of Notch1 activation in growing and differ-
entiating cardiac-committed nonmyocyte cells in vitro. Cultures of nonmyocyte cells isolated from neonatal hearts were maintained in expansion condi-
tions and stained for activated Notch1 (N1IC, green) and Nkx2.5 (red). The cultures were shifted to differentiation conditions and stained either for N1IC 
(green) and Nkx2.5 (red) in the middle column or for N1IC (green) and     -actinin (red) in the right column. Arrows indicate cardiac-committed or differen-
tiated cardiomyocyte nuclei lacking N1IC staining. (B) Quantitative RT-PCR analysis of expression of markers of cardiac differentiation. Nonmyocyte cells 
were maintained in differentiation medium or control medium and analyzed by quantitative RT-PCR for the expression of the indicated genes. Down-
regulation of Jagged1 and Hes1 expression during nonmyocyte differentiation in vitro is also presented. The expression levels are relative to controls 
maintained in expansion medium. Results are presented as the mean of three independent experiments. (C) Pharmacological and genetic inhibition of 
Notch accelerates differentiation in vitro. On the left, nonmyocyte cultures were established from WT neonatal mouse hearts and placed in differentiation 
medium in presence of vehicle alone (DMSO) or the     -secretase inhibitor DAPT. On the right, nonmyocyte cultures were established from WT or 
Notch1lox/lox MLC2vCre  +   (N1 del  ) newborn mice and placed in differentiation medium. RNA was isolated from the differentiated cultures and analyzed by 
semiquantitative RT-PCR for the expression of the indicated genes. Representative results of three independent experiments are shown.  Bar,  20   μ m.   JEM VOL. 205, December 22, 2008 
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a protective mechanism enabling cell survival. Indeed, mice 
lacking Notch1 in the heart demonstrate increased apoptotic 
cell death during the adaptive response to hemodynamic over-
load. Consistent with this, a recent study suggests that Notch 
activates protective signaling in the myocardium; specifi  cally, 
cross talk between hepatocyte growth factor and its cognate 
receptor c-Met, the Akt  –  PKB signaling pathway, and Notch 
regulates survival mechanisms in cardiomyocytes (  34  ). 
  There is a striking diff  erence between the cardiac pheno-
type that develops in TG1306/1R transgenic mice receiving 
a     -secretase inhibitor (short-term inhibition) and that ob-
served in hypertensive cNotch1 KOs (long-term inhibition). In 
a chronic model of cardiac hypertrophy and failure (TG1306/1R 
transgenics), short-term Notch inhibition results in increased 
cardiac performance, which likely refl  ects enhanced protein 
synthesis and sarcomeric assembly in hypertrophic cardiomy-
ocytes. In contrast, long-term inhibition in Notch1-defi  cient 
mice with renovascular hypertension (1K1C model) leads to 
maladaptive remodeling characterized by diminished cardiac 
function. Notch1-defi  cient hearts demonstrate severe cardiac 
fi  brosis under conditions of hemodynamic overload associ-
ated with decreased animal survival. Tissue fi  brosis is a sign of 
a defi  cient regenerative capacity in normally self-renewing 
organs (  35  ). This observation suggests that cardiac dysfunc-
tion may result from decreased mobilization of CPCs and 
inadequate replacement of damaged cardiomyocytes. For 
exerts a dual role in the adult heart. On the one hand, Notch 
prevents uncontrolled growth of cardiomyocytes and might 
contribute to cell survival. On the other hand, Notch blocks 
cardiac diff  erentiation in the resident precursor population 
and may therefore allow expansion of a transient amplifying 
cell compartment. Blockade of the Notch pathway appears to 
be detrimental to the normal adaptation of the heart. Phar-
macological inhibition produces a down-regulation of Notch 
target genes such as Hes1, Hey1, and Hey2, activates cardiac 
gene expression, and exacerbates cardiac hypertrophy. Hey 
genes, Hey2 in particular, were shown to inhibit cardiac gene 
transcription (  30  ), to block ventricular expression of atrial 
genes during cardiac development (  31  ) and in the adult heart 
(  32  ), and to suppress cardiac hypertrophy via direct interac-
tion with the transcription factor GATA4 (  30, 33  ). Experi-
ments performed in embryonic stem cells lacking either 
Hey-2 or both Hey-1 and Hey-2 also suggest that Hey pro-
teins negatively regulate the transcription of GATA-4 and 
GATA-6 (  31  ). Therefore, Notch appears to limit the extent 
of cardiomyocyte hypertrophy by negatively regulating car-
diac gene expression. The reexpression of atrial genes, such as 
the atrial natriuretic factor, is a hallmark of the hypertrophic 
heart and likely contributes to alteration of cardiac function. 
Accordingly, cardiomyocytes lacking Notch1 demonstrate a 
stimulated cardiac gene program and a more mature (hyper-
trophic) phenotype. Notch activation may, therefore, represent 
    Figure 8.         Up-regulation of Jagged1 expression in the stressed heart.   (A)  Immunofl  uorescence analysis of Jagged1 expression in the heart. The 
micrograph shows Jagged1 expression on the surface of     -actinin  –  positive cardiomyocytes with an enlarged area shown in the inset. Nuclei are stained 
with DAPI. (B) Confocal micrograph showing Jagged1 expression on the surface of     -actinin  –  positive cardiomyocytes. Arrows in the inset indicate undif-
ferentiated Nkx2.5-positive     -actinin  –  negative CPCs lying between Jagged1-expressing fi  bers. The nuclei are stained with DAPI. (C) Heart tissue sections 
from sham-operated (sham) and clipped (1K1C) mice were subjected to alkaline phosphatase immunohistochemistry using an antibody directed against 
Jagged1. The representative micrographs show Jagged1 expression in the myocardium at 4, 8, and 12 d after surgery. (D) Jagged1 immunostaining in WT 
and TG1306/1R transgenic mice as in C. Bars: (A and B) 20   μ  m; (C and D) 100   μ  m.     3182 NOTCH1-MEDIATED CARDIAC RESPONSE TO STRESS   | Croquelois et al. 
Third, inhibition of the Notch pathway results in a striking 
up-regulation of cardiac gene expression both in vitro and in 
vivo. These Notch-mediated eff  ects are very similar to those 
observed in embryonic stem cells, where Notch inhibits me-
sodermal commitment, cardiac diff  erentiation (  41, 42  ), and 
cardiomyocyte production (  43  ). In contrast, forced N1IC 
expression in mesodermal cardiac progenitor cells expressing 
Mesp1 during development prevents cardiogenesis and re-
sults in cardiac abnormalities (  44  ). In cNotch1 KOs, the ab-
sence of Notch in transient amplifying cells could therefore 
induce premature diff  erentiation, leading to a gradual exhaus-
tion of the proliferating precursor pool, and aff  ect the adaptive 
capacity of the heart. 
  The activation of the Notch pathway in the heart in 
response to stress likely depends on Jagged1 expression on 
the surface of cardiomyocytes. This is indicated by the high 
level of Jagged1 in the heart of 1K1C hypertensive mice and 
TG1306/1R transgenic animals. Reciprocal activation of the 
Notch pathway could then occur between adjacent myocytes. 
Jagged1 expression is decreased in mice receiving a     -secretase 
inhibitor. This suggests that Notch-mediated inductive signal-
ing may take place between neighboring cells to regulate 
Jagged1 expression. Indeed, a positive-feedback mechanism 
has been shown to control Jagged1 expression in the developing 
heart during the onset of endocardial cushion formation (  17  ). 
Furthermore, Jagged1 on the surface of cardiomyocytes could 
also convey a signal to Notch1-positive CPCs lying in inter-
stitial spaces. Interestingly, decreasing Jagged1 expression is 
observed in cultures of diff  erentiating cardiac precursors, re-
sulting in a down-regulation of the Notch pathway. 
  In CPCs clusters, some cells appear to activate Notch and 
some do not. Moreover, in pairs of adjacent cells, Notch is 
often activated only in one cell. Because down-regulation of 
the Notch pathway favors cardiac diff  erentiation, it would be 
interesting to evaluate whether N1IC-positive cells are less 
advanced in their cardiogenic diff   erentiation than N1IC-
negative cells. Furthermore, it has yet to be determined whether 
cardiogenic diff  erentiation during postnatal cardiogenesis re-
quires asymmetrical CPC division, producing daughter cells 
preferentially expressing the Notch receptor or its ligand 
Jagged1. In the skeletal muscle, the maintenance and the prolif-
eration of satellite cells are dependent on an activated Notch 
pathway. Pools of transient activating cells are amplifi  ed in 
the damaged muscle after expression of the Notch ligand 
Delta-like (  39  ). Furthermore, the mechanism for initiating 
myogenic diff  erentiation in undiff  erentiated precursors im-
plicates the Notch antagonist Numb, which is asymmetrically 
distributed into dividing cells (  45  ). Cells that inherit Numb 
are committed to the myogenic lineage (  46  ). Interestingly, 
undiff  erentiated Numb-positive cells have been found in the 
adult mouse heart (  47  ). These cells could have undergone 
asymmetrical division similar to that seen during the regener-
ation of the skeletal muscle. Finally, it is noteworthy that the 
Notch-mediated regenerative capacity of skeletal muscle is 
gradually lost with age because of a decreased capacity to up-
regulate Notch ligand expression and to recruit precursor 
instance, zebrafi  sh can regenerate its partially amputated heart 
via proliferation of immature cardiomyocytes (  36  ). This pro-
cess relies in part on an activated Notch pathway (  37  ). In mutant 
fi  sh lacking this regenerative capacity, the failure to form a 
new compact myocardium leads to fi  brosis and scarring (  36  ). 
  Recently, evidence has accumulated suggesting that car-
diac myocytes can be continuously replaced in the heart through 
a process involving CPC replication and diff  erentiation. Our 
results demonstrate the existence of Notch-activating CPCs 
that can give rise to functional cardiomyocytes. N1IC-posi-
tive cells coexpress GATA4 and/or Nkx2.5 in vivo and dur-
ing expansion in vitro suggesting that CPCs are committed 
to the cardiogenic lineage. Interestingly, CPCs with an acti-
vated Notch1 pathway did not appear to express Sca-1, a 
widely used marker of CPCs in the heart. Whether Notch1 
signaling and Sca-1  –  positive CPCs represent two distinct steps 
toward cardiomyocyte diff  erentiation or two separate cardio-
genic lineages is still unclear. Furthermore, nonmyocyte cells 
with an activated Notch pathway express the proliferation 
marker Ki67 suggesting that these cells are actively cycling. 
In CPCs, down-regulation of Notch appears to be necessary 
for achieving terminal cardiac diff  erentiation. By preventing 
cardiogenesis, Notch signaling may therefore facilitate the 
expansion of transient amplifying cells. In this context, it is 
interesting to note that the number of BrdU-positive cells in 
Notch1-defi  cient hearts is signifi  cantly lower than that ob-
served in WT hearts under both basal and hemodynamic 
stress, indicating that proliferation of cardiac cells relies on a 
functional Notch1 pathway. The Notch pathway has been 
described to promote stem cell maintenance and proliferation 
in several diff  erent self-renewing organs (  38  ). For instance, ex-
pansion of satellite cells in the skeletal muscle is dependent on 
an activated Notch pathway (  39  ). In cNotch1 KOs, Notch1 
deletion is mediated by expression of the Cre recombinase 
under the control of the Mlc2v promoter. Therefore, the 
Notch pathway could act primarily in late committed precur-
sors and/or immature cardiomyocytes in which the MLC2v 
promoter is activated. In isolated cardiomyocytes, Notch1 
activation is associated with an immature phenotype charac-
terized by the absence of organized sarcomeres. Sarcomere 
disassembly is a prerequisite for cardiomyocyte proliferation 
(  40  ). The activation of the Notch pathway in cardiac myo-
cytes could either preserve the capacity of incompletely dif-
ferentiated cells to proliferate and/or facilitate the reentry of 
diff  erentiated cardiomyocytes into the cell cycle in part by 
inhibiting sarcomeric protein synthesis. Accordingly, Ki67-
positive cardiomyocytes with an activated Notch1 pathway 
are detected in the stressed heart. These cells could be pri-
marily aff  ected by Notch1 inactivation. 
  Blocking the Notch pathway promotes the diff  erentia-
tion of CPCs into cardiomyocytes and accelerates the matu-
ration of cardiomyocytes. These fi  ndings are supported by 
several observations. First, CPCs diff  erentiate more readily 
into cardiomyocytes when the Notch pathway is pharmaco-
logically or genetically inhibited. Second, sarcomeric struc-
tures are more elaborate in cardiomyocytes lacking Notch1. JEM VOL. 205, December 22, 2008 
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      -Secretase inhibition.     To inhibit the Notch pathway in vivo,     -secretase 
inhibitor was administered to 15-wk-old male TG1306 transgenic and WT 
littermates. Mice were injected every 12 h for 14 d with either 1.5 mg/kg of 
the     -secretase inhibitor LY411,575 (provided by H. Jacobsen, F Hoff  mann-
La Roche Ltd, Basel, Switzerland) in 0.9% NaCl and 0.3% Tween 80 (  25  ) 
or vehicle alone. On day 10, physiological measurements were performed. 
The cardiac weight index was determined at sacrifi  ce. Excised hearts were 
either processed for histological analysis or stored at     80  °  C until used. 
  Analysis of cardiac cell proliferation.     To analyze cell proliferation in 
vivo, 1 mg/ml BrdU was administered to 8-wk-old mice for 96 h in drink-
ing water containing 5% glucose. Mice were killed and hearts were removed 
and fi  xed in 4% paraformaldehyde in PBS. The hearts were dehydrated and 
processed for paraffi   n sectioning and immunostaining. 
  Analysis of apoptotic cell death.     To detect apoptotic cells in the myo-
cardium, paraffi   n or cryosections of heart tissue were analyzed using the In 
Situ Cell Detection kit (Roche). To simultaneously stain with myomesin, 
cryosections were fi  rst stained with antimyomesin antibody and a secondary 
Cy3 conjugate anti  –  mouse antibody, postfi  xed, and then processed for 
TUNEL assays. To quantitate apoptosis, sections were subjected to TUNEL 
assays, and the total number of positive nuclei was determined by counting 
under a fl  uorescence microscope. 
  Cell culture.     To isolate neonatal ventricular cardiomyocytes and mesen-
chymal nonmyocyte cells, ventricles were separated from the atria and 
minced. Tissues were digested in a solution containing 0.45 mg/ml collage-
nase (Worthington Biochemical Corporation) and 1 mg/ml pancreatin 
(EMD). Cardiomyocytes were separated from mesenchymal cells by two 
steps of diff  erential plating at 45 min each. Cardiomyocytes were plated on 
gelatinized plates in complete medium (a 3:1 mixture of DMEM and Me-
dium 199 supplemented with 10% horse serum, 5% fetal calf serum and anti-
biotics) and allowed to adhere overnight then maintained in a serum-free 3:1 
mixture of DMEM and Medium 199 and antibiotics. The mesenchymal 
nonmyocyte cells were maintained in complete medium. Culture of CPCs 
present in the mesenchymal fraction and induction of diff  erentiation into 
functional cardiomyocytes was performed as previously described (  7  ). In 
brief, diff  erentiation was induced in confl  uent cultures by maintaining cells 
in     -MEM, 10% FCS supplemented with 50   μ  g/ml of ascorbic acid, 10 mM 
    -glycerol phosphate, and 1   μ  M dexamethasone. Control cultures were 
maintained in the same medium without supplements. To inhibit Notch 
signaling, cells were treated with 1   μ  M DAPT (  N  -[  N  -(3,5-difl  uorophenace-
tyl)-l-alanyl]-S-phenylglycine t-butyl ester; EMD) dissolved in DMSO. 
Control cultures were treated with DMSO alone. 
  Semiquantitative and quantitative RT-PCR analysis.     RNA was ex-
tracted from cultured cells or heart tissue using TRIZOL reagent (Invitro-
gen). RNA was reverse transcribed into cDNA using oligo dT primers and 
MMLV reverse transcription according to the manufacturer  ’  s instructions 
(Invitrogen). PCR primers and conditions were essentially as described 
(  7, 42  ). Quantitative TaqMan analysis was performed using Gene Expression 
Assays (Applied Biosystems) on an ABI 7500 Thermal Cycler (Applied Bio-
systems). The relative gene expression levels were calculated using the com-
parative Ct method and are reported as ratios to those of the housekeeping 
genes GAPDH or     2 microglobulin as indicated. 
  Antibodies.     The following primary antibodies were used: rabbit antiacti-
vated N1IC (1:200; Abcam), mouse antimyomesin B4 (1:20; gift from J-C. 
Perriard, Die Eidgen  ö  ssische Technische Hochschule   Z  ü  rich  , Zurich, Swit-
zerland), mouse antisarcomeric     -actinin (1:500; Sigma-Aldrich), rabbit 
anti-Nkx2.5 (1:100; Santa Cruz Biotechnology, Inc.), goat anti-Nkx2.5 
(SC12514; 1:200; Santa Cruz Biotechnology, Inc.), goat anti  –  GATA-4 (SC-
1237; 1:100; Santa Cruz Biotechnology, Inc.), goat anti-Jagged1 (1:100; 
Santa Cruz Biotechnology, Inc.), rat anti-BrdU (1:200; Oxford Biotech), 
rabbit antilaminin (1:200; Sigma-Aldrich), rat anti  –  Sca-1 (1:100; BD), and 
cells (  39  ). It will be important to determine whether a similar 
regulation exists in the heart as this may provide a mechanism 
by which cardiac function and the capacity of the left ventri-
cle to adapt to hemodynamic overload decreases with age. If 
this is true, Notch may represent a novel therapeutic target 
for the treatment of cardiac diseases. 
  MATERIALS AND METHODS 
  Mice.     The transgenic mouse line TG1306/1R expressing angiotensinogen 
under control of the     -MHC promoter has been previously described 
(  23, 24  ). The cardiac Notch1 deletion was obtained by crossing mice harboring 
fl  oxed Notch1 allele (  29  ) with mice expressing the Cre recombinase under 
control of MLC2v promoter (  28  ). WT C57BL/6 mice were purchased from 
Charles River Laboratories. Mice were housed under standard conditions. 
Animal experiments were approved by the Government Veterinary Offi   ce 
(Lausanne, Switzerland) and performed according to the University of Laus-
anne Medical School institutional guidelines. 
  Microarray analysis.     Microarray experiments were performed on three 
diff  erent mouse groups: transgenic hypertrophic TG1306, transgenic dilated 
TG1306, and WT littermates, with the former two groups being distin-
guished on the basis of heart morphology, cardiac weight index, and expres-
sion of cardiac hypertrophy marker genes. Aliquots containing 25   μ  g of total 
RNA were reverse transcribed into dye-labeled cDNA with Superscript II 
reverse transcription (Invitrogen) in presence of Cy3- or Cy5-labeled dCTP 
(GE Healthcare). SpotReport Alien and Arabidopsis Spike RNAs (Strata-
gene) were used as controls. The dye-labeled cDNAs were purifi  ed using the 
MinElute PCR Purifi  cation kit (QIAGEN) after hydrolysis of the RNA 
template. Microarray slides (DNA Array Facility in Lausanne, Switzerland) 
contained the NIA 15K mouse embryonic clone set (National Institute of 
Aging, National Institutes of Health, Bethesda, MD) to which an additional 
1563 custom clone set was added. The slides were hybridized with heat-de-
natured Cy3 and Cy5 cDNA samples to be compared in 30   μ  l of hybridiza-
tion solution containing 0.33 mg/ml poly-A (Sigma-Aldrich), 0.33 mg/ml 
of yeast transfer RNA (Sigma-Aldrich), 0.66 mg/ml of mouse Cot1 DNA 
(Invitrogen). Hybridization was performed overnight in the dark in sealed 
hybridization chambers (TeleChem International, Inc.) at 64  °  C. After incu-
bation, the array slides were washed in washing solutions containing SSC, 
SDS, and Triton X-100, spun dry, and stored in a dark desiccated environ-
ment until scanning. The slides were scanned using a microarray laser scan-
ner (Agilent Technologies), which acquired two 16-bit grayscale images 
corresponding to the Cy5 and Cy3 fl  uorescence emission channels (excited 
with an argon laser operating at     650 and 550 nm, respectively). The images 
were processed with GenePix Pro 5.1 software (MDS Analytical Technolo-
gies) to produce a matrix containing Cy5 (red) and Cy3 (green) intensities 
for each spot on the microarray. The bulk of quality control and normaliza-
tion steps are automated and provided by in house  –  developed web tools us-
ing the open source Bioconductor packages from the statistical software R 
(R Foundation for Statistical Computing). 
  One kidney, one clip model.     In brief, 12-wk-old mice weighing 22  –  25 g 
were anaesthetized using 1.5% halothane in oxygen. The left kidney was ex-
posed and a clip (0.12-mm opening) was inserted on the renal artery isolated 
by blunt dissection. The contralateral kidney was removed. Sham procedure 
included the entire surgery with the exception of artery clipping (  27  ). 
  Physiological measurements.     Blood pressure was measured on conscious 
animals by the Tail-Cuff   method using a BP-2000 apparatus (Visitech Sys-
tems, Inc.). Cardiac dimensions and function were assessed in anesthetized 
mice (90 mg/Kg ketamine and 5 mg/Kg xylazine i.p.) by transthoracic 
echocardiography using an ultrasound machine (ATL HDI 5000; Philips) 
equipped with a 12-MHz phase array linear transducer (L12-5). M-mode 
images were used for the measurement of wall thickness, chamber dimen-
sion, and fraction of shortening. Cardiac weight index was defi  ned as the ra-
tio of heart weight/body weight (in milligrams/gram). 3184 NOTCH1-MEDIATED CARDIAC RESPONSE TO STRESS   | Croquelois et al. 
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goat anti-Ki67 (1:50; Santa Cruz Biotechnology, Inc.). For double immuno-
staining, the following combinations of secondary antibodies were used: bio-
tinylated donkey anti  –  rabbit (1:150; Jackson ImmunoResearch Laboratories) 
or biotinylated donkey anti  –  goat (1:150; Jackson ImmunoResearch Labora-
tories) plus Cy3- or Cy2-conjugated streptavidin (1:900; Jackson Immuno-
Research Laboratories), Cy3-conjugated goat anti  –  mouse (1:400; Jackson 
ImmunoResearch Laboratories), or Cy3-conjugated donkey anti  –  goat 
(1:200; Jackson ImmunoResearch Laboratories) antibodies. Jagged1 anti-
body binding was detected with horseradish peroxidase  –  conjugated anti  –
  mouse or anti  –  goat antibody and an UltraVision detection system (Thermo 
Fisher Scientifi  c) or Alexa Fluor 488  –  conjugated anti  –  goat antibody. BrdU 
antibody binding was detected using horseradish peroxidase  –  conjugated 
anti  –  rat antibody (1:200; Invitrogen) using diaminobenzidine as a substrate. 
  Immunofl  uorescence  detection.     Cultured cells or 5-  μ  m frozen tissue 
sections were fi  xed in 2 and 4% paraformaldehyde in PBS, respectively, per-
meabilized with 0.25% Triton X-100 in PBS, and blocked in PBS contain-
ing 0.001% Triton X-100, 1% BSA, and 1% FCS. Specimens were incubated 
overnight with primary antibodies, which were revealed by incubation for 
1 h at room temperature with fl  uorochrome-conjugated secondary antibodies. 
Sections were observed with a fl  uorescence microscope (AxioVision; Carl 
Zeiss, Inc.). Confocal microscopy was performed on a confocal microscope 
(SP5; Leica). Stained cells in culture were observed under an inverted fl  uo-
rescence microscope (LSR Eclipse TE2000S; Nikon). 
  Histology.     For histological analysis, hearts were dissected free from atria 
and vessels and fi  xed in 4% paraformaldehyde in PBS or 10% formalin. Stain-
ing included standard hematoxylin and eosin or Van Gieson staining. Fibro-
sis was quantifi  ed by computer-assisted densitometric morphometry (Image 
Pro Plus; Media Cybernetics). Collagen deposition was expressed as a per-
centage of total cross-sectional area. 
  Online supplemental material.     Fig. S1 shows that the Sca-1  +   cell popu-
lation in WT adult and neonatal hearts, as well as in adult TG1306/1R 
transgenic hearts, does not generally activate the Notch1 signaling pathway. 
Fig. S2 demonstrates the effi   cacy of the     -secretase inhibitor treatment in 
vivo by quantitating the disappearance of the Notch-dependent MZB cell 
population in the spleen of treated mice. Fig. S3 depicts the down-regula-
tion of the Notch1 signaling pathway in cardiomyocytes in the presence of 
the hypertrophic agent phenylephrine. Fig. S4 demonstrates that Notch-
signaling cardiomyocytes and nonmyocyte cells are actively cycling in the 
heart of TG1306/1R transgenic mice as shown by Ki67 staining. Table S1 
describes the TG1306/1R transgenic mice with either cardiac hypertrophy 
or dilated cardiomyopathy used in microarray analyses. Tables S2  –  S7 re-
port microarray analysis data obtained by comparing gene expression of WT 
hearts and either hypertrophic or dilated hearts from TG1306/1r transgenic 
mice. The data have been deposited in National Center for Biotechnology 
Information  ’  s Gene Expression Omnibus, and are accessible through GEO 
Series accession no.   GSE13336   (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE13336). Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20081427/DC1. 
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